Compare BALL & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BALL | ZBH |
|---|---|---|
| Founded | 1880 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6B | 19.5B |
| IPO Year | 2009 | 2001 |
| Metric | BALL | ZBH |
|---|---|---|
| Price | $58.70 | $82.54 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 21 |
| Target Price | $69.00 | ★ $101.00 |
| AVG Volume (30 Days) | ★ 2.5M | 2.4M |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | ★ 1.33% | 1.20% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.77 | ★ 1.22 |
| Revenue | N/A | ★ $8,231,500,000.00 |
| Revenue This Year | $7.96 | $4.96 |
| Revenue Next Year | $3.51 | $3.76 |
| P/E Ratio | $76.16 | ★ $68.46 |
| Revenue Growth | N/A | ★ 7.20 |
| 52 Week Low | $44.83 | $79.83 |
| 52 Week High | $68.56 | $108.29 |
| Indicator | BALL | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 41.17 | 34.51 |
| Support Level | $56.63 | $79.83 |
| Resistance Level | $62.11 | $96.69 |
| Average True Range (ATR) | 1.73 | 2.53 |
| MACD | -0.44 | -0.65 |
| Stochastic Oscillator | 20.10 | 16.59 |
Ball is the world's largest metal can manufacturer with market share over 30% in its three main regions (North America, Europe, and South America). The company is focused on increasing capacity amid a wave of new developed-market demand, while also investing in faster-growing emerging-market economies. Ball spun-off its glass jar business in 1993 and is now owned by Newell. The company reports three segments-beverage packaging, North and Central America (48% of 2025 revenue), beverage packaging, EMEA (30%), beverage packaging, South America (16%)-and it generated $13 billion in revenue in 2025.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.